hyperlipoidemia acute pancreatitis
Conditions
Interventions
Experimental Group:therapuetic plasma exchange
control group:Continuous renal replacement therapy
Sponsors
Department of Blood Transfusion, The Second Affiliated Hospital, Army Medical University.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Acute pancreatitis (AP) with blood TG=11.3 mmol and excludion of other causes including biliary obstruction and alcohol ; or blood TG value between 5.65-11.3mmol / L with chyle-like serum.
Exclusion criteria
Exclusion criteria: (1) A history of cardiopulmonary insufficiency; (2) A history of liver and kidney failure in the past; (3) History of mental illness; (4) Combined with pancreatic cancer; (5) Acute attack on the basis of chronic pancreatitis; (6) Those who did not complete the blood lipid examination within 72 hours after admission; (7) Acute pancreatitis caused by other pathogenic factors, such as biliary stones, micro stones, Oddi sphincter dysfunction, bacterial viral infection, drug-induced acute pancreatitis; (8) A history of severe allergies to plasma, human albumin, and heparin. (9) Informed refusal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum ltriglyceride, TG;Serum amylase;Serum Lipase;modified CT severity index;Ranson evaluation;acute physiology and chronic health evaluation,APACHE-II;modified Marshall evaluation;complication;length of stay; LOS;C reactive protein;Symptom relief time; | — |
Countries
China
Contacts
Public ContactLi Zhongjun
Department of Blood Transfusion, The Second Affiliated Hospital, Army Medical University.
Outcome results
None listed